Stay updated on ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Sign up to get notified when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.

Latest updates to the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedSummary of changes: added a government-status notice and updated version to v3.2.0; removed reference to v3.1.0.SummaryDifference11%

- Check26 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new version is available.SummaryDifference0.3%

- Check41 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.7%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%

- Check55 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference23%

- Check69 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%

Stay in the know with updates to ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.